Organic Chemistry TRIZ Cases

Bifunctional compounds recruit MDM2 to E3 ligase for ubiquitination and degradation, improving target specificity in cancer therapy.

Blending lower- and higher-alkyl citrate esters balances plasticization efficiency with lower migration, volatile loss, and better heat resistance.

A mesogenic epoxy structure builds liquid crystal-like phonon pathways, raising cured thermal conductivity beyond filler-limited EMCs.

Multiple titanation with a titanium extractant removes low-activity sites, improving stereoselectivity and xylene solubles control with less donor use.

A specific salt and resin combination improves resist pattern formation by reducing line edge roughness without overly complicating composition design.

Purine-linked tricyclic scaffolds improve JAK1 selectivity, inhibition activity, and water solubility for autoimmune and cancer therapy.

Solvent-free amino methacrylate addition products improve UV LED surface cure under oxygen inhibition while reducing migration and yellowing.

Polycyclic non-fullerene acceptors improve solubility, synthesis, charge mobility, and oxidation stability in organic electronic devices.

Small-molecule αvβ6 inhibitors use tailored fluorinated linkers to balance target potency with in vitro permeability for oral treatment.

A soluble OLED compound combines multiple organic layer functions, enabling fully solution-processed fabrication with better efficiency and lifetime.

Modular enzyme pathways raise DPA in plant and microbial lipids to 7%–35% while keeping DHA below 2% for sustainable supply.

An isoindoline derivative acts as a growth inhibitor and rheology modifier to control pigment crystal size while preserving color strength and thermal stability.

Compounds with tailored substituent patterns improve ATM kinase inhibition potency and selectivity while supporting lower-toxicity cancer treatment.

Irreversible BTK inhibition mobilizes lymphoid cells into blood for biomarker profiling and better sequencing of therapy in refractory B-cell cancers.

A phenolic antioxidant and organic ester work together to slow peroxide decomposition, preserving shelf life, color, fragrance, and cleaning performance.

A fused-ring host material improves red or near-infrared OLED emission while maintaining heat resistance, low driving voltage, and longer lifetime.

Novel formula I compounds use N-linked bicyclic or spirocyclic rings to improve NLRP3 inhibition with better pharmacological properties.

A stable aficamten polymorph, Form Z1 combines high purity with controlled preparation to avoid form conversion during storage.

Calix[4]arenes bind and transport copper across membranes to disrupt copper homeostasis and kill chemoresistant cancer cells.

Nickel catalysts and methyl zinc reagents raise yield, suppress side-products, and enable scalable synthesis without palladium.

Bifunctional Degronimers link a target-binding ligand to a cereblon degron to improve selective protein degradation for cancer and blood disorders.

Specific HOMO and triplet energy matching across host materials helps organic EL layers sustain luminous efficiency and longer lifetime.

Biodegradable ester-bond ionizable lipids improve nucleic acid encapsulation and delivery while reducing inflammation and hepatotoxicity.

Structural changes in piperidine XPO1 inhibitors preserve cancer cell killing while reducing the systemic toxicities seen with Selinexor.

A citraconimide-epoxy resin blend lowers melt and room-temperature viscosity while preserving dielectric performance and heat resistance.

A luciferin-luciferase reagent emits light on contact with SARS-related coronaviruses, enabling rapid detection without complex PCR workflows.

Bio-derived anhydromevalonolactone replaces NMP and DCM in polymer dissolution and paint removal while lowering toxicity and fire risk.

Narrow-spectrum substituted tetracyclines target acne bacteria and inflammation while improving photostability and oxidative stability.

A one-pot reagent system deprotects and converts alpha halides to alkenyl or aldehyde products with high purity, fewer steps, and greener reagents.

Modular cereblon-binding degraders use linkers and targeting ligands to selectively recruit proteins for ubiquitin-proteasome degradation.

Dual NK-1/NK-3 antagonists lower LH and testosterone to treat sex-hormone diseases while avoiding flare, injection reactions, and other side effects.

A bimodal macropore-mesopore catalyst cuts diffusion resistance during ortho-alkylation, sustaining selectivity and conversion without cocatalysts.

Ionizable lipid nanoparticles protect nucleic acid drugs from degradation and improve cell membrane penetration for in vivo and in vitro delivery.

A KOtBu-based route forms key Ribociclib intermediates under mild conditions, avoiding heavy metals and silica gel purification.

A biaryl TNAP inhibitor raises pyrophosphate while improving solubility, permeability, and bioavailability to suppress ectopic calcification.

Asymmetric heterocyclic compounds boost triplet-triplet fusion in OLED emission layers, improving efficiency, luminance, driving voltage, and lifespan.

Novel RORγ inverse agonists address limited treatment efficacy by modulating inflammatory pathways and improving disease severity outcomes.

A carbonate-linked flavor compound prevents room-temperature volatilization, then releases flavor on heating to improve storage life and taste.

A Formula I compound uses tuned substituents to inhibit multiple KRAS mutants, supporting cancer treatment where conventional approaches fall short.

Aromatic amide derivatives target KIF18A to inhibit tumor cell proliferation, induce apoptosis, and support selective cancer therapy.

A fluorine-free onium salt resist composition improves acid dispersion to preserve low line width roughness during storage.

Specific methyl-substituted bisphenol compounds improve methanol color, thermal stability, and molecular weight control in polycarbonate resin production.

Selective FGFR2 compounds improve anti-tumor response while reducing FGFR1-linked hyperphosphatemia that limits pan-FGFR dosing.

Pre-mixing the palladium source, ligand, and base cuts Axitinib reaction time and lowers Pd residue for easier purification.

Selective ETA receptor antagonism with atrasentan lowers proteinuria, inflammation, and fibrosis while delaying ESRD in IgA nephropathy.

Isolated amino acids combined with nitrate compounds improve bioabsorption and rapid vasodilation while reducing dose requirements.

Isoxazole-substituted hydroxamic acids improve HDAC6 selectivity while preserving anticancer activity and sensitizing cancer cells to therapy.

Novel pyrrolidine compounds selectively modulate the glucocorticoid receptor to preserve anti-inflammatory activity while minimizing adverse effects.

Selective glycolysis inhibitors deplete ATP and reduce off-target kinase binding to address resistant AR-positive prostate cancer.

An intermediary emitting-auxiliary layer and tuned HOMO levels improve OLED charge balance, color purity, efficiency, and lifetime.